Rodney Tyrone Perkins, 583508 Frigatebird Ln, North Las Vegas, NV 89084

7766895, Aug 3, 2010

Apr 12, 2005

11/104717

Peter P. Soltesz - Henderson NV, US
Anthony D. Wondka - Thousand Oaks CA, US
Rodney A. Perkins - Woodside CA, US
Robert Kotmel - Burlingame CA, US

Pulmonx Corporation - Redwood City CA

A61M 31/00

604516

Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.

2019038, Dec 26, 2019

Sep 5, 2019

16/562158

- Redwood City CA, US
Peter Soltesz - Henderson NV, US
Anthony Wondka - Thousand Oaks CA, US
Rodney Perkins - Woodside CA, US

Pulmonx Corporation - Redwood City CA

A61B 5/00
A61B 5/08
A61B 5/083
A61B 5/085
A61B 5/087
A61B 6/00
A61B 8/12
A61M 16/04
A61M 25/00
A61M 25/10
A61B 5/055

The present invention provides systems, methods, devices and kits for assessing the level of pulmonary disease in individual lung compartments. A lung compartment comprises a subportion of a lung, such as a lobe, a segment or a subsegment, for example. By measuring individual lung compartments, the level of disease of the pulmonary system may be more precisely defined by determining values of disease parameters reflective of individual subportions or compartments of a lung. Likewise, compartments may be separately imaged to provide further measurement information. Once individual compartments are characterized, they may be compared and ranked based on a number of variables reflecting, for example, level of disease or need for treatment. Such comparison may be aided by simultaneous display of such variables or images on a visual display. Further, the same tests may be performed on the lung as a whole or on both lungs and to determine the affect of the diseased lung compartments on the overall lung performance. In addition, the diseased lung compartments may be temporarily isolated and the measurement tests performed to determine the affect of the isolation on overall lung performance. As a result, the most beneficial treatment options may be selected.

2016024, Sep 1, 2016

May 9, 2016

15/150324

- Redwood City CA, US
Peter Soltesz - Henderson NV, US
Anthony Wondka - Thousand Oaks CA, US
Rodney Perkins - Woodside CA, US

A61B 5/00
A61B 5/085
A61B 6/00
A61B 8/12
A61B 5/055
A61B 5/087
A61B 5/08

The present invention provides systems, methods, devices and kits for assessing the level of pulmonary disease in individual lung compartments. A lung compartment comprises a subportion of a lung, such as a lobe, a segment or a subsegment, for example. By measuring individual lung compartments, the level of disease of the pulmonary system may be more precisely defined by determining values of disease parameters reflective of individual subportions or compartments of a lung. Likewise, compartments may be separately imaged to provide further measurement information. Once individual compartments are characterized, they may be compared and ranked based on a number of variables reflecting, for example, level of disease or need for treatment. Such comparison may be aided by simultaneous display of such variables or images on a visual display. Further, the same tests may be performed on the lung as a whole or on both lungs and to determine the affect of the diseased lung compartments on the overall lung performance. In addition, the diseased lung compartments may be temporarily isolated and the measurement tests performed to determine the affect of the isolation on overall lung performance. As a result, the most beneficial treatment options may be selected.

2016003, Feb 11, 2016

Oct 21, 2015

14/919480

- Redwood City CA, US
Peter Soltesz - Henderson NV, US
Anthony Wondka - Thousand Oaks CA, US
Rodney Perkins - Woodside CA, US

A61B 5/087
A61M 25/10
A61M 25/00
A61B 5/08
A61B 5/085
A61M 16/04

The present invention provides systems, methods, devices and kits for assessing the level of pulmonary disease in individual lung compartments. A lung compartment comprises a subportion of a lung, such as a lobe, a segment or a subsegment, for example. By measuring individual lung compartments, the level of disease of the pulmonary system may be more precisely defined by determining values of disease parameters reflective of individual subportions or compartments of a lung. Likewise, compartments may be separately imaged to provide further measurement information. Once individual compartments are characterized, they may be compared and ranked based on a number of variables reflecting, for example, level of disease or need for treatment. Such comparison may be aided by simultaneous display of such variables or images on a visual display. Further, the same tests may be performed on the lung as a whole or on both lungs and to determine the affect of the diseased lung compartments on the overall lung performance. In addition, the diseased lung compartments may be temporarily isolated and the measurement tests performed to determine the affect of the isolation on overall lung performance. As a result, the most beneficial treatment options may be selected.